24-hour Movement Behaviors Among Type 2 Diabetes Mellitus Patients

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

A healthy lifestyle has proved beneficial health effects in managing type 2 diabetes mellitus (T2DM). Important lifestyle behaviors, i.e. sleep, sedentary time (SB), and physical activity (PA) subdivided into light physical activity (LPA) and moderate to vigorous physical activity (MVPA), have shown an impact on T2DM disease-specific characteristics (e.g. glycemic control). However, these behaviors have often been investigated separately. Therefore, a recent shift in research emphasizes the importance of considering these behaviors as part of a 24-hour day. Since T2DM patients can benefit from an optimal 24-hour composition as part of a healthy lifestyle, it may be interesting to investigate the 24-hour movement composition among these T2DM patients over time. Moreover, exploring associations with different personal determinants, environmental determinants, and cardiometabolic markers will provide meaningful insights in developing recommendations and creating an intervention.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: t
View:

• Adults aged \>18 years old

• Diagnosed with T2DM by a physician or an HbA1C above 6.5%

⁃ \- Adults aged \> 18 years old

Locations
Other Locations
Belgium
Ghent University Hospital, Dept. of Endocrinology
RECRUITING
Ghent
Contact Information
Primary
Iris Willems, PhD student
willems.iris@ugent.be
093323638
Backup
Marieke De Craemer, Professor
Marieke.Decraemer@ugent.be
09 332 52 08
Time Frame
Start Date: 2021-08-29
Estimated Completion Date: 2026-12-01
Participants
Target number of participants: 248
Treatments
type 2 diabetes mellitus group
124 adults with type 2 diabetes mellitus will be included
control group
124 control adults will be included
Related Therapeutic Areas
Sponsors
Collaborators: University Ghent
Leads: University Hospital, Ghent

This content was sourced from clinicaltrials.gov